Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database
抗CD38抗体治疗多发性骨髓瘤(包括三线耐药患者)的真实世界疗效数据:来自加拿大骨髓瘤研究组(CMRG)数据库的多中心报告
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00946-z
Visram, A; De La Torre, A; White, D; Su, J; Masih-Khan, E; Chu, M; Jimenez-Zepeda, V; McCurdy, A; LeBlanc, R; Song, K; Mian, H; Louzada, M; Sebag, M; Bergstrom, D; Stakiw, J; Reiman, A; Kotb, R; Aslam, M; Venner, C; Kaedbey, R; Gul, E; Reece, D